Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 81.66%119.51M | 12.99%344.7M | -6.95%131.13M | 32.18%67.92M | 51.02%70.96M | 51.30%305.07M | 61.71%140.92M | 60.94%65.79M | 18.79%51.38M | 54.75%46.99M |
| Cost of revenue | 91.57%101.21M | 10.50%263.92M | -6.12%103.2M | 25.64%50.64M | 54.31%55.22M | 77.69%238.84M | 81.48%109.92M | 104.77%52.83M | 37.73%40.31M | 90.56%35.78M |
| Gross profit | 41.25%18.3M | 21.97%80.78M | -9.90%27.93M | 55.99%17.28M | 40.50%15.74M | -1.48%66.23M | 16.65%30.99M | -14.06%12.96M | -20.83%11.08M | -3.30%11.2M |
| Operating expense | 50.04%6.43M | 40.25%29.63M | 78.12%11.68M | -15.17%5.24M | 54.64%6.36M | 158.62%21.13M | 248.54%6.56M | -12.10%4.29M | 66.26%6.18M | 2.90%4.11M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | -14.61%23.99M | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | -14.61%23.99M | ---- | ---- | ---- | ---- |
| Other operating expenses | 50.04%6.43M | 40.25%29.63M | 78.12%11.68M | -15.17%5.24M | 54.64%6.36M | --21.13M | --6.56M | -12.10%4.29M | 66.26%6.18M | 2.90%4.11M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | -33.98%13.16M | ---- | ---- | ---- | ---- |
| Operating profit | 36.91%11.87M | 13.40%51.15M | -33.52%16.24M | 145.63%12.04M | 32.29%9.38M | -23.62%45.1M | -21.14%24.44M | -15.00%8.67M | -52.31%4.9M | -6.56%7.09M |
| Net non-operating interest income (expenses) | -72.29%-4.15M | -55.82%-18.32M | -104.03%-8.05M | 31.96%-2.5M | -63.19%-2.83M | 14.22%-11.76M | 30.08%-3.95M | 10.74%-2.41M | -12.17%-3.67M | 17.22%-1.74M |
| Non-operating interest expense | 72.29%4.15M | 55.82%18.32M | 104.03%8.05M | -31.96%2.5M | 63.19%2.83M | -14.22%11.76M | -30.08%3.95M | -10.74%2.41M | 12.17%3.67M | -17.22%1.74M |
| Net investment income | 95.58%-91K | 887.94%9.01M | 598.74%5.52M | -97.88%59K | 452.91%2.67M | -1.14M | -1.11M | -95.07%-2.06M | 330.27%2.78M | 24.10%-756K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -17.79%2.76M | -54.40%5.85M | 17.96%3.64M | -70.65%1.29M | -29.69%1.41M | 12.82M | 3.09M | 3.81%3.35M | 41.95%4.38M | -38.43%2M |
| Income before tax | 37.45%10.38M | 5.92%47.68M | -22.76%17.36M | 29.75%10.89M | 60.92%10.62M | -0.71%45.02M | 18.07%22.47M | -21.91%7.56M | -5.58%8.39M | -14.81%6.6M |
| Income tax | -54.49%481K | -93.02%718K | -97.87%160K | -88.36%177K | 0.00%176K | -8.15%10.28M | -13.35%7.53M | -27.40%1.06M | 366.26%1.52M | -75.69%176K |
| Net income | 52.40%9.9M | 35.20%46.97M | 15.08%17.2M | 55.86%10.71M | 62.58%10.45M | 1.72%34.74M | 44.46%14.94M | -20.94%6.5M | -19.73%6.87M | -8.54%6.43M |
| Net income continuous operations | 52.40%9.9M | 35.20%46.97M | 15.08%17.2M | 55.86%10.71M | 62.58%10.45M | 1.72%34.74M | 44.46%14.94M | -20.94%6.5M | -19.73%6.87M | -8.54%6.43M |
| Noncontrolling interests | 0 | 99.94%-1K | 0 | 0 | 0.00%-1K | -13,658.33%-1.65M | 80.00%-1K | 0 | -54,866.67%-1.65M | 50.00%-1K |
| Net income attributable to the company | 52.40%9.9M | 29.07%46.97M | 15.07%17.2M | 25.71%10.71M | 62.57%10.45M | 6.52%36.39M | 44.40%14.94M | -20.98%6.5M | -0.51%8.52M | -8.55%6.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 52.40%9.9M | 29.07%46.97M | 15.07%17.2M | 25.71%10.71M | 62.57%10.45M | 6.52%36.39M | 44.40%14.94M | -20.98%6.5M | -0.51%8.52M | -8.55%6.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 32.50%0.0053 | 13.96%0.0253 | 3.33%0.0093 | 9.43%0.0058 | 55.00%0.0062 | -2.63%0.0222 | 36.36%0.009 | -25.93%0.004 | -10.17%0.0053 | -18.37%0.004 |
| Diluted earnings per share | 30.77%0.0051 | 16.82%0.025 | 3.41%0.0091 | 11.76%0.0057 | 56.41%0.0061 | -3.17%0.0214 | 33.33%0.0088 | -26.42%0.0039 | -10.53%0.0051 | -17.02%0.0039 |
| Dividend per share | 0 | 0.00%0.001 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0.001 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.